Adimmune Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 82.55 million compared to TWD 526.94 million a year ago. Net loss was TWD 240.71 million compared to net income of TWD 45.3 million a year ago. Basic loss per share from continuing operations was TWD 0.57 compared to basic earnings per share from continuing operations of TWD 0.11 a year ago. Diluted loss per share from continuing operations was TWD 0.57 compared to diluted earnings per share from continuing operations of TWD 0.11 a year ago.
For the six months, sales was TWD 252.26 million compared to TWD 579.73 million a year ago. Net loss was TWD 489.72 million compared to TWD 189.31 million a year ago. Basic loss per share from continuing operations was TWD 1.16 compared to TWD 0.44 a year ago. Diluted loss per share from continuing operations was TWD 1.16 compared to TWD 0.44 a year ago.